JN.1 COVID-19 VARIANT: CLARIFYING PROTOCOLS
Why in the News?
- The World Health Organization (WHO) classifies JN.1 as a ‘variant of interest’ on December 19, 2023, belonging to the BA.2.86 Omicron lineage.
- 1 raises global concern due to its rapid spread, prompting increased COVID-19 cases.
Source: COVID communication Network
About JN.1 Variant:
- The JN.1 variant carries the L455S mutation in the spike protein, potentially affecting its ability to bind to human cells.
- WHO states no evidence of additional public health risk from JN.1, but with the winter onset, it could heighten respiratory infections globally.
- Existing vaccines, according to the Centers for Disease Control and Prevention, remain effective against JN.1, minimizing the need for booster shots.
Situation in India:
- India reports JN.1 cases from Kerala and Goa.
- India witnesses a rise in COVID-19 cases, exceeding 4,000 active cases, and a slight increase in fatalities.
About Variant of Interest (VOI)
A variant is designated as a Variant of Interest (VOI) if it exhibits growth advantages or changes in transmissibility, virulence, or susceptibility to therapies. About World Health Organization · Establishment: WHO founded on April 7, 1948 is a specialized agency of the United Nations. · Headquarters: Geneva, Switzerland. · Functions: Focuses on international public health and coordinates global health efforts, provides guidelines, and responds to health emergencies. · Achievements: Instrumental in eradicating smallpox, addressing global health challenges, and shaping health policies worldwide |